Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), a biotechnology company, focuses on discovering and developing therapeutics based on Tumor Hypoxia, a powerful scientific platform that offers broad potential to treat most solid tumors. The company is currently building a pipeline of drugs that may be more effective and less toxic to healthy tissues than conventional drugs. Their staff consists of research scientists and business professionals with successful track records in the biotech industry. For further information, visit the Company’s web site at www.thresholdpharm.com.
- 17 years ago
QualityStocks
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Portfolio in Walker Lane Hotspot
As Nevada’s Walker Lane becomes a prime target for mineral exploration, Lahontan Gold (TSX.V: LG) (OTCQB:…
-
QualityStocksNewsBreaks – Adageis’ Platform Tackles Healthcare Complexities with AI
Adageis was featured in a recent article that discussed its powerful and patented AI-centric software solution.…
-
ONAR Holding Corp. (ONAR): In Marketing’s AI Era, Strategy is Beating Speed
ONAR's network of technology-first agencies focuses on data-driven strategy and execution over flashy, reactive campaigns…